Literature DB >> 2861468

Sublingual captopril in hypertensive crisis.

W Tschollar, G G Belz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2861468     DOI： 10.1016/s0140-6736(85)90073-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  The effect of captopril on peripheral hemodynamics in patients with essential hypertension: comparison between oral and sublingual administration.

Authors:  C Longhini; L Ansani; G Musacci; D Mele; M Vaccari; E Baracca; P Sgobino
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Sublingual captopril--a pharmacokinetic and pharmacodynamic evaluation.

Authors:  T A al-Furaih; J C McElnay; J S Elborn; R Rusk; M G Scott; J McMahon; D P Nicholls
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Pheochromocytoma.

Authors:  C Reuse; J L Vincent; C Matos; M de Rood; J Unger
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. Ireland, 6-8 July, 1988. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

5.  Effect of a single dose of sublingual captopril in hypertensive patients.

Authors:  J H Hauger-Klevene
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

6.  Sublingual captopril in hypertensive urgencies.

Authors:  A Misra; P Jain; R B Reddy
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

7.  The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels.

Authors:  Hein A van Onzenoort; Michiel Bussink; Paul P Menheere; Walther N van Mook; Paul-Hugo M van der Kuy
Journal:  Pharm World Sci       Date:  2006-09-27

Review 8.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

9.  Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors.

Authors:  B Santos Ramos; M J Piña Vera; E Carvajal Gragera; M Atienza Fernández
Journal:  Pharm World Sci       Date:  1993-10-15

10.  The ankyrin repeat gene family in Capsicum spp: Genome-wide survey, characterization and gene expression profile.

Authors:  Carlos Lopez-Ortiz; Yadira Peña-Garcia; Purushothaman Natarajan; Menuka Bhandari; Venkata Abburi; Sudip Kumar Dutta; Lav Yadav; John Stommel; Padma Nimmakayala; Umesh K Reddy
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.